on 19 Nov 2024
Last Applicant/ Owned by
10230 Jasper Avenue
Edmonton, Alberta
CA
T5J4P6
Serial Number
97978410 filed on 14th Sep 2022
Registration Number
7568415 registered on 19th Nov 2024
Correspondent Address
Theodore R. Remaklus
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
Advisory services relating to gene therapy research; research in the field of gene therapy; research and development of vaccinesand medicines; information on the subject of scientific research in the field of biotechnology; genetic testing for scientific researchpurposes; scientific research in the field of genetics and genetic engineering; research and development in the pharmaceuticaland biotech Read More
Medical therapy services, namely gene therapy services; medical analysis services, namely RNA or DNA analysis for virusdiagnosis and prognosis; medical information services, namely, providing information to physicians, healthcare professionals andpatients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic,prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; on-line information services, namely,providing medical information to physicians, healthcare professionals and patients on the topics of health issues that can betreated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines,recombinant proteins and antibodies; genetic testing for medical purpose
31st Mar 2011
31st Mar 2011
Advisory services relating to gene therapy research; research in the field of gene therapy; research and development of vaccinesand medicines; information on the subject of scientific research in the field of biotechnology; genetic testing for scientific researchpurposes; scientific research in the field of genetics and genetic engineering; research and development in the pharmaceuticaland biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products; scientificresearch, pharmaceutical research, medical research, technical consultation in the field of pharmaceutical studies and productdevelopment for others in the field of biotechnology and product development of pharmaceuticals, therapeutic agents and medicaldevices; research and product development in the field of human vaccines, recombinant proteins and antibodies for therapeuticuse; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant proteinplatform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; medical and scientificresearch services relating to infectious diseases; development of new products for others in the field of pharmaceuticals,pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regardingclinical trial studies on new vaccine candidates
31st Mar 2011
31st Mar 2011
Custom manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies forothers; custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins andantibodies
31st Mar 2011
23rd Jan 2018
No 97978410
No Service Mark
No TORYS-97-122
Yes
Yes
No
No
No
No
No
No
26.01.09 -
Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle
26.01.18 -
Three or more concentric circles
26.01.21 -
Circles that are totally or partially shaded
Status Date | Action Taken |
---|---|
19th Nov 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
19th Nov 2024 | REGISTERED-PRINCIPAL REGISTER |
03rd Sep 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
03rd Sep 2024 | PUBLISHED FOR OPPOSITION |
14th Aug 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
25th Jul 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
25th Jun 2024 | DIVISIONAL PROCESSING COMPLETE |
12th Jun 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
06th Apr 2024 | ASSIGNED TO LIE |
16th Nov 2023 | DIVISIONAL REQUEST RECEIVED |